Pages that link to "Q39366437"

The following pages link to HDAC2 overexpression confers oncogenic potential to human lung cancer cells by deregulating expression of apoptosis and cell cycle proteins (Q39366437):

Displaying 43 items.

• Histone Deacetylases and Their Regulatory MicroRNAs in Hepatocarcinogenesis (Q26783620) (← links)
• Histone deacetylases as targets for treatment of multiple diseases (Q27000389) (← links)
• New and emerging HDAC inhibitors for cancer treatment (Q27022413) (← links)
• Suberoylanilide hydroxamic acid increases anti-cancer effect of tumor necrosis factor-α through up-regulation of TNF receptor 1 in lung cancer cells (Q33566645) (← links)
• Modulation of microRNA expression in human lung cancer cells by the G9a histone methyltransferase inhibitor BIX01294. (Q33727680) (← links)
• HDAC2 overexpression correlates with aggressive clinicopathological features and DNA-damage response pathway of breast cancer (Q33733042) (← links)
• MicroRNA-455 suppresses the oncogenic function of HDAC2 in human colorectal cancer (Q33821384) (← links)
• Pyrroloquinoline Quinone Induces Cancer Cell Apoptosis via Mitochondrial-Dependent Pathway and Down-Regulating Cellular Bcl-2 Protein Expression (Q34084843) (← links)
• Histone deacetylases and cancer. (Q34298745) (← links)
• Recombinant human alpha fetoprotein synergistically potentiates the anti-cancer effects of 1'-S-1'-acetoxychavicol acetate when used as a complex against human tumours harbouring AFP-receptors (Q35687188) (← links)
• Epigenetic Alterations in Fanconi Anaemia: Role in Pathophysiology and Therapeutic Potential. (Q35806891) (← links)
• Reconstruction of gene regulatory networks reveals chromatin remodelers and key transcription factors in tumorigenesis. (Q36915248) (← links)
• Chemopreventive effects of an HDAC2-selective inhibitor on rat colon carcinogenesis and APCmin/+ mouse intestinal tumorigenesis (Q37405334) (← links)
• Histone deacetylases: a saga of perturbed acetylation homeostasis in cancer (Q37416288) (← links)
• Histone deacetylase inhibitors provoke a tumor supportive phenotype in pancreatic cancer associated fibroblasts (Q37745937) (← links)
• Role of histone deacetylase 2 in epigenetics and cellular senescence: implications in lung inflammaging and COPD (Q38030311) (← links)
• Epigenetic regulation of cell signaling pathways in acute lymphoblastic leukemia (Q38141135) (← links)
• Regulatory variation: an emerging vantage point for cancer biology (Q38164307) (← links)
• Histone deacetylase inhibitors in hematological malignancies and solid tumors (Q38344675) (← links)
• Overexpression of histone deacetylase 2 predicts unfavorable prognosis in human gallbladder carcinoma (Q38398975) (← links)
• FKBP3 Promotes Proliferation of Non-Small Cell Lung Cancer Cells through Regulating Sp1/HDAC2/p27. (Q38609274) (← links)
• Metal-dependent Deacetylases: Cancer and Epigenetic Regulators (Q38747135) (← links)
• Histone Modifications and Cancer (Q38796064) (← links)
• Histone deacetylase 2 regulates doxorubicin (Dox) sensitivity of colorectal cancer cells by targeting ABCB1 transcription (Q38796545) (← links)
• HDACs and HDAC Inhibitors in Cancer Development and Therapy (Q38947405) (← links)
• Differential expression of histone deacetylase and acetyltransferase genes in gastric cancer and their modulation by trichostatin A. (Q39011776) (← links)
• Oncogenic potential of CK2α and its regulatory role in EGF-induced HDAC2 expression in human liver cancer (Q39016576) (← links)
• Phenotypic impact of deregulated expression of class I histone deacetylases in urothelial cell carcinoma of the bladder. (Q39051488) (← links)
• Histone deacetylases inhibitor trichostatin A increases the expression of Dleu2/miR-15a/16-1 via HDAC3 in non-small cell lung cancer (Q39123831) (← links)
• Epigenetic Modifications and Head and Neck Cancer: Implications for Tumor Progression and Resistance to Therapy (Q39433158) (← links)
• Novel histone deacetylase inhibitor N25 exerts anti-tumor effects and induces autophagy in human glioma cells by inhibiting HDAC3. (Q47105964) (← links)
• Primary cilia proteins: ciliary and extraciliary sites and functions. (Q47228439) (← links)
• Using Histone Deacetylase Inhibitors to Analyze the Relevance of HDACs for Translation. (Q51374040) (← links)
• Investigating piwi-interacting RNA regulome in human neuroblastoma. (Q52667529) (← links)
• Quantitative phosphoproteomic analysis reveals γ-bisabolene inducing p53-mediated apoptosis of human oral squamous cell carcinoma via HDAC2 inhibition and ERK1/2 activation. (Q53416230) (← links)
• The PI3K/AKT pathway promotes gefitinib resistance in mutant KRAS lung adenocarcinoma by a deacetylase-dependent mechanism. (Q54423334) (← links)
• HADC regulates the diabetic vascular endothelial dysfunction by targetting MnSOD (Q59126000) (← links)
• HDAC4 gene silencing alleviates epilepsy by inhibition of GABA in a rat model (Q61800390) (← links)
• HDAC2 Inhibitor Valproic Acid Increases Radiation Sensitivity of Drug-Resistant Melanoma Cells (Q64062830) (← links)
• Histone deacetylase 2 is involved in DNA damage-mediated cell death of human osteosarcoma cells through stimulation of the ATM/p53 pathway (Q64233937) (← links)
• The Metallome of Lung Cancer and its Potential Use as Biomarker (Q64277403) (← links)
• FKBP3 mediates oxaliplatin resistance in colorectal cancer cells by regulating HDAC2 expression (Q90119719) (← links)
• Role of Histone Deacetylases in Carcinogenesis: Potential Role in Cholangiocarcinoma (Q90632680) (← links)